• News

    Regulatory Opportunities and Challenges in Osteoporosis

    Date: August 29, 2011
    Join Theresa Kehoe, M.D. of the US Food and Drug Administration and Javier San Martin, M.D., from Amgen, Inc. as they discuss regulatory opportunities and challenges in osteoporosis on Friday, September 16 from 11:00am-12:00pm in Room 20BCD.. Dr. Kehoe will present the FDA perspective, FDA priorities and overall directions and Dr. San Martin will provide industry perspective. Following the presentations, a panel discussion will be moderated by Gayle Lester, Ph.D., National Institute of Arthritis and Musculoskeletal and Skin Diseases.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details